A case of crossed cerebellar diaschisis on follow-up positron emission tomography/computed tomography with (18F) fluoro-D-glucose after treatment for glioblastoma

• Published in: World journal of nuclear medicine Vol. 18; no. 1; pp. 71 - 73
• Main Authors: Priftakis, Dimitrios, Rondogianni, Phivi, Datseris, Ioannis
• Format: Journal Article
• Language: English
• Published: A-12, 2nd Floor, Sector 2, Noida-201301 UP, India Thieme Medical and Scientific Publishers Pvt. Ltd 01.01.2019; Wolters Kluwer India Pvt. Ltd; Medknow Publications and Media Pvt. Ltd; Medknow Publications & Media Pvt. Ltd; Medknow Publications & Media Pvt Ltd
• Subjects: Blood flow; Brain; Brain cancer; Case Report; Chemotherapy; Computation; Computed tomography; Glucose; Lesions; Medical imaging; Medical prognosis; Metabolism; Nuclear medicine; Oxygen consumption; Patients; Positron emission; Stroke; positron emission tomography/computed tomography; glioblastoma; Crossed cerebellar diaschisis; fluoro-D-glucose; stroke
• ISSN: 1450-1147; 1607-3312
• DOI: 10.4103/wjnm.WJNM_15_18

Abstract Crossed cerebellar diaschisis (CCD) represents the reduction of blood flow, metabolism, and oxygen consumption in the cerebellar hemisphere contralateral to a cerebral focal lesion. This phenomenon is the result of remote metabolic effects of cerebral lesions and it has been described since the first attempts for functional imaging of the brain, almost 40 years ago. Nevertheless, its clinical significance remains uncertain and new ways to use imaging of CCD for prognosis or assessment of novel therapies are being investigated. In this report, we present treatment for glioblastoma as a cause of CCD imaged on positron emission tomography/computed tomography with ( 18 F) fluoro-D-glucose in our department.